Molnupiravir

ATC J05AB18 · 4 markets · 6 records

Molnupiravir 4 markets · 6 records Forms

AU 3 records · 2 strengths

200 mgcapsuleLagevrio 200mg capsules+1LAGEVRIO molnupiravir 200 mg capsules bottle also in GB·CN unknown

Records without a stated strength · 1 Lagevrio 200mg capsules

GB 1 records · 1 strengths

200 mgcapsuleLagevrio 200mg capsules also in AU·CN

CN 1 records · 1 strengths

200 mgcapsule利卓瑞莫诺拉韦 also in AU·GB

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Lagevrio 200mg capsules

Side-by-side table

Strength / form / release	GB	AU	CN	EU
200 mgRecorded as: 0.2 g capsule	Lagevrio 200mg capsules	Lagevrio 200mg capsules LAGEVRIO molnupiravir 200 mg capsules bottle	利卓瑞莫诺拉韦	not recorded
not disclosed unknown	not recorded	Lagevrio 200mg capsules	not recorded	Lagevrio 200mg capsules

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.